RAC 0.00% $1.61 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-165

  1. 19,079 Posts.
    lightbulb Created with Sketch. 5881
    It certainly is very disturbing, but given the enormous effort and funds required to get a scientific discovery to patients it is not surprising.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.